Drug Shortage Report for SUPREFACT
| Report ID | 220741 |
| Drug Identification Number | 02225166 |
| Brand name | SUPREFACT |
| Common or Proper name | Buserelin acetate injection |
| Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | BUSERELIN |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 2 x 5.5 ml |
| ATC code | L02AE |
| ATC description | HORMONES AND RELATED AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-02-28 |
| Actual start date | |
| Estimated end date | 2024-06-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-02-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-02-29 | English | Compare |
| v3 | 2024-02-27 | French | Compare |
| v2 | 2024-02-27 | French | Compare |
| v1 | 2024-02-27 | English | Compare |
Showing 1 to 4 of 4